Omeros (OMER) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.53% |
| Dec 31, 2025 | 34.29% |
| Sep 30, 2025 | 6.56% |
| Jun 30, 2025 | 6.75% |
| Mar 31, 2025 | -4.17% |
| Dec 31, 2024 | 1.06% |
| Sep 30, 2024 | -11.16% |
| Jun 30, 2024 | -27.31% |
| Mar 31, 2024 | -4.73% |
| Dec 31, 2023 | 20.90% |
| Sep 30, 2023 | 5.83% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.32% |
| Dec 31, 2022 | 51.79% |
| Sep 30, 2022 | -40.31% |
| Jun 30, 2022 | -14.87% |
| Mar 31, 2022 | -13.13% |
| Dec 31, 2021 | -10.76% |
| Sep 30, 2021 | -1.15% |
| Jun 30, 2021 | -20.11% |
| Mar 31, 2021 | -8.45% |
| Dec 31, 2020 | -2.90% |
| Sep 30, 2020 | -4.48% |
| Jun 30, 2020 | -6.75% |
| Mar 31, 2020 | -0.77% |
| Dec 31, 2019 | 1.00% |
| Sep 30, 2019 | 9.38% |
| Jun 30, 2019 | 11.36% |
| Mar 31, 2019 | 1.53% |
| Dec 31, 2018 | -57.20% |
| Sep 30, 2018 | -11.98% |
| Jun 30, 2018 | -7.84% |
| Mar 31, 2018 | -9.16% |
| Dec 31, 2017 | -2.53% |
| Sep 30, 2017 | 20.69% |
| Jun 30, 2017 | 2.78% |
| Mar 31, 2017 | 3.20% |
| Dec 31, 2016 | 0.44% |
| Sep 30, 2016 | -3.23% |
| Jun 30, 2016 | -5.92% |
| Mar 31, 2016 | -12.47% |
| Dec 31, 2015 | -8.87% |
| Sep 30, 2015 | -8.65% |
| Jun 30, 2015 | -4.10% |